AlphaStocks

ELV vs HQY

As of Sep 20, 2026, Elevance Health (ELV) scores 6.3/10 and Healthequity (HQY) 6.5/10 on AlphaStocks' five-model composite, so HQY scores higher. ELV trades 30% below its model fair value; HQY trades 45% above its model fair value.

ELV

Elevance Health, Inc.

6.3

Consider Buy

$410.92

HQY

HEALTHEQUITY, INC.

6.5

Consider Buy

$95.13

ELV vs HQY: Which is the Better Investment?

Elevance Health, Inc. (ELV) scores 6.3/10 while HEALTHEQUITY, INC. (HQY) scores 6.5/10 on AlphaStocks' composite model. HEALTHEQUITY, INC. has the higher composite rating of Consider Buy. On a P/E basis, Elevance Health, Inc. trades at 16.3x, making it the more attractively priced of the two. Elevance Health, Inc. trades further below its estimated fair value.

This comparison is algorithmically generated and is not financial advice.

MetricELVHQY
Scores & Fundamentals
Composite Score6.3/106.5/10
RatingConsider BuyConsider Buy
Price$410.92$95.13
P/E Ratio16.338.7
ROE12.9%10.1%
Market Cap$91B$8B
Fair Value$587.51$65.60
Dividend Yield1.7%
Sector Rank#34 of 168#30 of 168
Model Verdicts
PiotroskiAttractiveStrong
BuffettNeutralAttractive
GrahamCautionCaution
LynchNeutralNeutral
GreenblattAttractiveNeutral
View full ELVanalysis →View full HQYanalysis →

Related comparisons

Compare any two stocks →

ELV vs HQY: Which Stock Scores Higher?

Elevance Health, Inc. (ELV) and HEALTHEQUITY, INC. (HQY) are both in the Health Care sector. HQY currently leads with a composite score of 6.5/10 (Consider Buy) compared to ELV's 6.3/10 (Consider Buy).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer